Exhibit No. 10.73 EMPLOYMENT AGREEMENT Employment Agreement dated as of January 15, 1997 between Seragen, Inc. (the "Company"), having an office at 97 South Street, Hopkinton, Massachusetts 01748, and Elizabeth Chen ("Chen"), residing at 122 West...Employment Agreement • April 2nd, 1997 • Seragen Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 2nd, 1997 Company Industry Jurisdiction
WAIVER NO. 2Seragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 1997 IndustryReference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned and as amended by Waiver to Employment Agreement dated as of January 6, 1997 between the Company and the undersigned (together the "Agreement"). Pursuant to Section 3.6 (viii) of the Agreement, the Company agreed to grant Dr. Nichols certain additional options upon the occurrence of certain events.
Exhibit No. 10.66 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT Amendment No. 1 to Employment Agreement (the "Amendment") dated as of December 18, 1996 between Seragen, Inc. (the "Company") and Reed Prior ("Prior"). WHEREAS, the Company and Prior entered an...Employment Agreement • April 2nd, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
Contract Type FiledApril 2nd, 1997 Company Industry
Exhibit No. 10.67 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT Amendment No. 1 to Employment Agreement (the "Amendment") dated as of December 18, 1996 between Seragen, Inc. (the "Company") and Jean C. Nichols, Ph.D. (the "Executive"). WHEREAS, the Company...Employment Agreement • April 2nd, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
Contract Type FiledApril 2nd, 1997 Company Industry
WAIVERSeragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 1997 IndustryReference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned (together the "Agreement"). Pursuant to the Agreement, the Company agreed to file a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Prior pursuant to the Agreement on or before January 6, 1997.
March 28, 1997 Seragen, Inc. 97 South Street Hopkinton, MA 01748 Re: Employment Agreement Gentlemen: The undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the...Seragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 1997 IndustryThe undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the undersigned and Seragen, Inc. (the "Company") does not include the sale of the Company's manufacturing and clinical operations facilities to Boston University or Boston University's designated affiliate pursuant to the Assets Purchase Agreement dated as of February 14, 1997 between the Company and Boston University.
March 28, 1997 Seragen, Inc. 97 South Street Hopkinton, MA 01748 Re: Employment Agreement Gentlemen: The undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the...Seragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 1997 IndustryThe undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the undersigned and Seragen, Inc. (the "Company") does not include the sale of the Company's manufacturing and clinical operations facilities to Boston University or Boston University's designated affiliate pursuant to the Assets Purchase Agreement dated as of February 14, 1997 between the Company and Boston University.
Exhibit No. 10.69 WAIVERSeragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 1997 IndustryReference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned (together the "Agreement"). Pursuant to the Agreement, the Company agreed to file a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Nichols pursuant to the Agreement on or before January 6, 1997.